Excellence in Oncology conference
Take part in the debate on ANGIOGENESIS INHIBITORS IN CURRENT TREATMENT FOR BREAST CANCER
We are pleased to announce the first e-survey of Excellence in Oncology 2012, Istanbul - Turkey, 22-25 February 2012 (EiO 2012).
Excellence in Oncology wants to hear your voice in view of the debate session organised during the conference on “Do angiogenesis inhibitors add anything but cost to current treatment for breast cancer?”. Your feedback will be given for consideration to the Debate speakers, Norman Wolmark, Chairman of NSABP, US (PRO) and David Miles*, Medical Oncologist, UK (CON).
* invited



